News Breaks |
|
|
| October 29, 2012 |
| 05:55 EDT |  | CYTX, CYTX, LIFE, LIFE, RHHBY, RHHBY, SHPG, SHPG, SGMO, SGMO, CI, CI, ACTC, ACTC, PFE, PFE, STEM, STEM, NBS, NBS, ATHX, ATHX | Alliance for Regenerative Medicine to hold a forum
2012 Stem Cell Meeting on the Mesa's Investor & Partnering Forum is being held in La Jolla, California on October 29-30. |
|
|
News For CYTX;NBS;STEM;PFE;ACTC;CI;SGMO;SHPG;RHHBY;LIFE;ATHX From The Last 14 Days Check below for free stories on CYTX;NBS;STEM;PFE;ACTC;CI;SGMO;SHPG;RHHBY;LIFE;ATHX the last two weeks. |
|
|
| May 23, 2013 |
| 08:14 EDT | | PFE | Carter's
Global Consumer Products Analysts discuss the possibility of China retiring the one-child policy within the year and potential implications for consumer products on an Analyst/Industry conference call. Relevant covered companies JNJ, PG, PFE, ABT, KMB, MJN and CRI which may be impacted and discussed on the Analyst/Industry conference call to be held on May 23 at 10 am. |
|
| May 22, 2013 |
| 12:08 EDT |  | SGMO | Options with decreasing implied volatility: ARNA SGMO NTAP CBST GDI
|
|
| 10:33 EDT |  | RHHBY | Bristol-Myers jumps after Citi ups rating on cancer potential
 Subscribe for More Information |
|
| 10:00 EDT |  | RHHBY | On The Fly: Analyst Upgrade Summary
Subscribe for More Information |
|
| 08:59 EDT | | PFE | On The Fly: Pre-market Movers
Subscribe for More Information |
|
| 08:06 EDT | | PFE | Zoetis comments on Pfizer’s split-off plans for remaining interest
Subscribe for More Information |
|
| 08:04 EDT | | PFE | Pfizer announces plan to split-off remainder of Zoetis
Subscribe for More Information |
|
| 08:02 EDT | | PFE | Pfizer announces plan to split-off remainder of Zoetis
Subscribe for More Information |
|
| 06:02 EDT | | RHHBY | Roche upgraded to Buy from Neutral at Citigroup
Subscribe for More Information |
|
| May 21, 2013 |
| 20:03 EDT |  | RHHBY, LIFE | Roche, Sigma-Aldrich teamed for Life bid, Reuters says
Subscribe for More Information |
| |
| 11:41 EDT | | SGMO | Options with decreasing implied volatility: SGMO WCRX NTI TSLA AMRN
|
|
| 10:00 EDT |  | LIFE | On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Acquity Group (AQ) downgraded to Neutral from Buy at Roth Capital... Beazer Homes (BZH) downgraded to Neutral from Buy at Sterne Agee... CME Group (CME) downgraded to Neutral from Outperform at Macquarie... Carnival (CCL) downgraded to Neutral from Buy at UBS... Coach (COH) downgraded to Equal Weight from Overweight at Morgan Stanley... Deutsche Bank (DB) downgraded to Neutral from Overweight at JPMorgan... First Republic Bank (FRC) downgraded to Hold from Buy at Jefferies... Franklin Resources (BEN) downgraded to Neutral from Outperform at Macquarie... Life Technologies (LIFE) downgraded to Underperform from Outperform at CLSA... Oil States (OIS) downgraded to Neutral from Buy at Sterne Agee... Raymond James (RJF) downgraded to Market Perform from Outperform at Wells Fargo... VF Corp. (VFC) downgraded to Market Perform from Outperform at Wells Fargo... WellCare (WCG) downgraded to Neutral from Buy at Goldman... Huaneng Power (HNP) downgraded to Neutral from Buy at Citigroup... Comerica (CMA) downgraded to Neutral from Buy at DA Davidson... Beazer Homes (BZH) downgraded at Sterne Agee... Oil States (OIS) downgraded at Sterne Agee... eHealth (EHTH) downgraded to Neutral from Buy at Lazard Capital... Carnival (CCL) downgraded to Market Perform from Outperform at Wells Fargo... Warner Chilcott (WCRX) downgraded to Neutral from Positive at Susquehanna. |
|
| 07:16 EDT | | PFE | Pfizer management to meet with Leerink
Subscribe for More Information |
|
| 06:26 EDT | | LIFE | Life Technologies downgraded to Underperform from Outperform at CLSA
CLSA downgraded Life Technologies citing the takeout bid by Thermo Fisher. Price target is $76. |
|
| May 20, 2013 |
| 17:26 EDT | | RHHBY | Regeneron, Genentech, Sanofi enter into 'Zaltrap agreement'
Subscribe for More Information |
|
| 17:20 EDT | | RHHBY | Regeneron,, Bayer, Genentech resolve certain patent disputes
Subscribe for More Information |
|
| 17:04 EDT | | PFE | Pfizer discontinues phase 3 study of inotuzumab ozogamicin
Subscribe for More Information |
|
| 11:56 EDT | | SGMO | Options with decreasing implied volatility: SGMO WCRX TSLA CSC SUPN
|
|
| 10:03 EDT | | SHPG | Shire advances after report renews takeover speculation
Subscribe for More Information |
|
| 07:27 EDT | | SHPG | American Psychiatric Association to host annual meeting
Subscribe for More Information |
| |
|
|
|
|
